Jefferies Group LLC Kodiak Sciences Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$110.45 - $164.47 $110,450 - $164,470
-1,000 Closed
0 $0
Q4 2020

Sep 21, 2023
BUY
$60.78 - $154.03 $60,780 - $154,030
1,000 New
1,000 $146,000
Q4 2020

Feb 16, 2021
BUY
$60.78 - $154.03 $60,780 - $154,030
1,000 New
1,000 $147,000

Others Institutions Holding KOD

# of Institutions
98
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email